The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing

Overview of attention for article published in mBio, August 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 1 news outlet
policy: 3 policy sources
twitter: 28 X users
patent: 6 patents

facebook: 2 Facebook pages
wikipedia: 1 Wikipedia page
guideline: 2 clinical guideline sources

Readers on

mendeley: 784 Mendeley

So far, Altmetric has seen 2 public wall posts from 2 users.

Citizen News Service CNS, 31 Aug 2017

This paper describes the design principles and analytical performance of the new Xpert MTB/RIF Ultra assay co-developed by FIND.

FIND, 31 Aug 2017

This paper describes the design principles and analytical performance of the new Xpert MTB/RIF Ultra assay co-developed by FIND

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity.